Peripheral Blood Stem Cell Transplantation Clinical Trial
Official title:
Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen for Patients With Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma Underwenting Haploidenticl Peripheral Blood Stem Cell Transplantation
The purpose of this study is to determine the efficacy and safety of Ruxolitinib and Chidamide intensified conditioning regimen in patients with Acute T cell Lymphoblast leukemia/ lymphoblastic lymphoma Underwenting Haploidenticl Peripheral blood Stem Cell Transplantation.
Haploidenticl Peripheral blood Stem Cell Transplantation should be offered to eligible patients with Acute T cell Lymphoblast leukemia/ lymphoblastic lymphoma whenever feasible. To further improve the outcome of transplantation patients with Acute T cell Lymphoblast leukemia/ lymphoblastic lymphoma, we developed a modified Bu/Cy conditioning regimen intensified by Ruxolitinib and Chidamide. In this study, we tested the efficacy and feasibility of the modified Bu/Cy conditioning regimen intensified by Ruxolitinib and Chidamide in patients with Acute T cell Lymphoblast leukemia/ lymphoblastic lymphoma undergoing allogeneic peripheral blood stem cell transplantation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04582604 -
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05436418 -
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT03993639 -
KRN125 for Mobilization of Hematopoietic Stem Cells
|
Phase 2 | |
| Completed |
NCT02398708 -
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
|
||
| Completed |
NCT00575809 -
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
|
||
| Completed |
NCT00670423 -
A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation
|
Phase 1 | |
| Terminated |
NCT02326675 -
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
|
N/A | |
| Recruiting |
NCT05153226 -
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG
|
Phase 3 | |
| Recruiting |
NCT02848105 -
Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD
|
Phase 2 | |
| Not yet recruiting |
NCT03771222 -
Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies
|
Phase 2 | |
| Completed |
NCT02512679 -
Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
|
Phase 2 | |
| Recruiting |
NCT05088226 -
Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen
|
Phase 2 | |
| Recruiting |
NCT05961410 -
Eltrombopag for Peripheral Blood Stem Cell Harvest
|
Phase 2 |